PAM
TBRA

Panagora Asset Management’s Tobira Therapeutics, Inc. Common Stock TBRA Stock Holding History

Panagora Asset Management’s Portfolio TBRA Stock Details TBRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-46,343
Closed -$509K – 2518
2015
Q1 		$509K Sell
46,343
-113,036
-71% -$1.21M ﹤0.01% 1308
2014
Q4 		$1.31M Buy
159,379
+96,927
+155% +$834K 0.01% 909
2014
Q3 		$635K Buy
+62,452
New +$1.23M ﹤0.01% 1223
2014
Q2 		– Sell
-4,313
Closed -$486K – 2445
2014
Q1 		$486K Buy
+4,313
New +$303K ﹤0.01% 1429

Other funds holding TBRA

NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
CPV
Canaan Partners VII Westport, Connecticut $32.3M AUM 154.97% 1-Year Est. Return
A
Abingworth London, United Kingdom $307M AUM 93.47% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Panagora Asset Management's TBRA Position: Q2 2015 in Review

Panagora Asset Management sold out of Tobira Therapeutics, Inc. Common Stock (TBRA) in Q2 2015, closing a stake of 46,343 shares — an estimated $509K sold.

Panagora Asset Management first reported a position in TBRA in Q1 2014 and held it in 4 quarters. The position peaked at $1.31M in Q4 2014. 42 funds tracked by Wall St. Rank hold TBRA as of Q2 2015.

  • Panagora Asset Management reported no remaining Tobira Therapeutics, Inc. Common Stock position as of Q2 2015 after selling out during the quarter.
  • Panagora Asset Management sold 46,343 Tobira Therapeutics, Inc. Common Stock shares in Q2 2015, an estimated $509K.
  • Panagora Asset Management first reported a position in Tobira Therapeutics, Inc. Common Stock in Q1 2014 and held it in 4 quarters.
  • Panagora Asset Management's Tobira Therapeutics, Inc. Common Stock position peaked at $1.31M in Q4 2014.
  • 42 funds tracked by Wall St. Rank held Tobira Therapeutics, Inc. Common Stock as of Q2 2015.

Based on Panagora Asset Management's 13F filing for Q2 2015, filed 14 Aug 2015.